General Information of the Compound
Compound ID
CP0453092
Compound Name
4-(4-Methyl-piperazin-1-yl)-1H-benzoimidazole
    Show/Hide
Structure
Formula
C12H16N4
Molecular Weight
216.288
Canonical SMILES
CN1CCN(CC1)c1cccc2[nH]cnc12
    Show/Hide
InChI
InChI=1S/C12H16N4/c1-15-5-7-16(8-6-15)11-4-2-3-10-12(11)14-9-13-10/h2-4,9H,5-8H2,1H3,(H,13,14)
    Show/Hide
InChIKey
VNORITPQZHTCHX-UHFFFAOYSA-N
Physicochemical Property
logP
1.3147
Rotatable Bonds
1
Heavy Atom Count
16
Polar Areas
35.16
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
3
Complexity
16

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 10465905
SID: 15488472
ChEMBL ID
CHEMBL73967
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01354, 5-hydroxytryptamine receptor 6
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki > 1000 nM
   TI
   LI
   LO
   TS